New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Colorado blames Biden team and drugmakers for delaying Canadian imports

Colorado blames Biden team and drugmakers for delaying Canadian imports

by Phil Galewitz, KFF Health NewsCredit: CC0 Public DomainColorado officials say their plan to import cheaper medicines from Canada has been stymied by opposition from drugmakers and inaction by the B
Breakthroughs January 26,2024
Colorado blames Biden team and drugmakers for delaying Canadian imports

Colorado blames Biden team and drugmakers for delaying Canadian imports

by Phil Galewitz, KFF Health NewsCredit: CC0 Public DomainColorado officials say their plan to import cheaper medicines from Canada has been stymied by opposition from drugmakers and inaction by the B
Breakthroughs January 26,2024
Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

bySt. Jude Children's Research HospitalTwo leucine zipper motifs endow ZipRs with constitutive signal transduction.a, Schematic of IL-2 receptor-based Zip2Rs with phosphorylated (p) JA
Oncology January 26,2024
Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

bySt. Jude Children's Research HospitalTwo leucine zipper motifs endow ZipRs with constitutive signal transduction.a, Schematic of IL-2 receptor-based Zip2Rs with phosphorylated (p) JA
Oncology January 26,2024
Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer

Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended prog
Breakthroughs January 26,2024
Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer

Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended prog
Breakthroughs January 26,2024
Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J
Oncology January 26,2024
Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J
Oncology January 26,2024
Combined antibiotics more effective against Lyme disease: Study

Combined antibiotics more effective against Lyme disease: Study

by Leslie Tate,Tulane UniversityThe study findings could pave the way for improved Lyme disease treatments, particularly in persistent cases, said lead researcher Monica Embers, PhD, associate p
Breakthroughs January 26,2024
Combined antibiotics more effective against Lyme disease: Study

Combined antibiotics more effective against Lyme disease: Study

by Leslie Tate,Tulane UniversityThe study findings could pave the way for improved Lyme disease treatments, particularly in persistent cases, said lead researcher Monica Embers, PhD, associate p
Breakthroughs January 26,2024
Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

by Laura Kelley,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainMost Coloradans look at winter as a time of excitement when the high country turns into our own winter wonderland with
Q & A January 26,2024
Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

by Laura Kelley,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainMost Coloradans look at winter as a time of excitement when the high country turns into our own winter wonderland with
Q & A January 26,2024
New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

by Allessandra DiCorato,Broad Institute of MIT and HarvardCytokine production map by cell type. Credit:Nature(2023). DOI: 10.1038/s41586-023-06816-9The immune system can carry out ma
Breakthroughs January 26,2024
New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

by Allessandra DiCorato,Broad Institute of MIT and HarvardCytokine production map by cell type. Credit:Nature(2023). DOI: 10.1038/s41586-023-06816-9The immune system can carry out ma
Breakthroughs January 26,2024
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Oncology January 26,2024
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Oncology January 26,2024
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
Breakthroughs January 26,2024
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
Breakthroughs January 26,2024
New hybrid treatment forces cancer cells to starve

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor
Oncology January 26,2024
New hybrid treatment forces cancer cells to starve

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor
Oncology January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com